Cormorant Asset Management, LP - CONNECT BIOPHARMA HLDGS LTD ownership

CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 17 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of CONNECT BIOPHARMA HLDGS LTD
ValueSharesWeighting
Q4 2021$1,030,000
-91.4%
200,000
-60.0%
0.06%
-87.4%
Q3 2021$11,950,000
-5.9%
500,000
-23.1%
0.49%
+12.8%
Q2 2021$12,694,000
-31.4%
650,000
-35.0%
0.43%
+4.6%
Q1 2021$18,500,0001,000,0000.41%
Other shareholders
CONNECT BIOPHARMA HLDGS LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 597,678$771,0000.24%
Kynam Capital Management, LP 739,649$954,0000.20%
RA Capital Management 6,991,003$9,018,0000.19%
Octagon Capital Advisors LP 450,000$581,0000.10%
Ikarian Capital, LLC 219,501$283,0000.06%
UBS OCONNOR LLC 613,931$792,000,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,277,519$1,648,0000.00%
ROCKY MOUNTAIN ADVISERS, LLC 1,200$2,0000.00%
CSS LLC/IL 38,721$50,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 26,867$35,0000.00%
View complete list of CONNECT BIOPHARMA HLDGS LTD shareholders